Last week I sat down with @billgates to talk about global vaccine inequity, why COVAX has failed to curb it, his foundation more generally and Germany’s role in global health. Interview (€, in German) here and a few points in English to come:
On Covax:
He told me one huge problem was the complete absence of US leadership on this.
Another one was basically bad luck: COVAX bet on vaccines that were cheaper and more easily distributed than the mRNA vaccines and many of these have hit snags
(It is worth remembering that the bulk of globally available doses so far have been of just four vaccines: Astra-Zeneca, Pfizer and Sinopharm and Sinovac. Of these, Covax only bet early on AZ. Others it was counting on like J&J or Novavax have hit snags along the way.)
COVAX then had another problem, when India stopped exports of the AZ vaccine being produced there.
Though there had been an agreement to export half of the vaccine, given the escalating crisis at home, India changed its mind and there was little COVAX could do, Gates told me.
I asked him about countries like Germany pledging money to COVAX but then buying up vaccines before COVAX had any money in the bank to buy itself. And @DrTedros recent piece arguing companies should prioritise COVAX now, which you can read here: journals.plos.org/globalpubliche…
@DrTedros His response was that the situation is changing. India was now producing more vaccine than is needed domestically and would restart exports, he told me:
“We're finally getting to the point where supply of vaccine over the next three or four months will not be the limiting factor"
@DrTedros I asked about the TRIPS waiver of course and put it to him that we might be in a different situation now if that had been done a year ago.
His response: “That is the stupidest thing I ever heard” (editors decided to make that the headline by the way 🤷♂️)
@DrTedros “We are going to be swimming in COVID vaccines in mid-22”, Gates told me. "But if you want to discourage pharma innovation, I think it's brilliant. You should always threaten them that they won't have any IP.”
I told him companies had made billions.
He said a waiver did nothing.
@DrTedros (He argues that waiving IP rights does not change anything, something that imho may be true in the short term but not in the long term. Instead, he argues for second-source deals and if you want to know more he makes that case here, for instance: edition.cnn.com/2021/10/13/opi…)
@DrTedros I also asked about structural issues. Why not put more money into general health system strengthening for instance?
His response: Global ODA budget is $140 billion a year and that is not enough. @gavi and @GlobalFund are the two things he is proudest of, he says.
@DrTedros@gavi@GlobalFund Isn’t the problem that philanthropists are not accountable to anyone?
People should not rely on philanthropy for things like a decent healthcare system or education system, he told me. Increasing taxes locally is the way to go.
@DrTedros@gavi@GlobalFund Philanthropy is fairly small, he told me, and so it has to concentrate on high impact things like trying to eradicate diseases
“I hope during the lifetime of the Gates Foundation, which is between now and something like 2050, we can eradicate measles, we can eradicate malaria…"
@DrTedros@gavi@GlobalFund Finally, on Germany:
He said the country’ had taken on a much bigger role and it was night-and-day compared to a few years ago.
“It looks like people are proud of that. And I wish even more Germans knew about it and got to go to Africa and see the benefits of what's been done."
@DrTedros@gavi@GlobalFund When the UK recently reduced it’s ODA budget from 0.7% to 0.5% of the economy there was not any real public outcry, he said, and it would be hard to get the UK back to 0.7%.
That Germany is now (finally) at 0.7% gives it added weight going into the G7 presidency, he argues.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Some scientists have become twitter celebrities in this pandemic - bringing power as well as hate.
I talked to @devisridhar - a constant presence in my twitter feed the last two years - about her experience
First of all: This story is part of a @NewsfromScience series on the “new normal” and just a brief peek at some of the issues scientists are grappling with in this time of viral posts and a pandemic virus. It’s a huge topic and I want to hear more stories and see more research…
But briefly:
One of the most amazing things early on in this pandemic was watching science (and policy) debates play out in real-time online. Some researchers have helped hundreds of thousands of people make sense of what’s going on and make informed decisions. They saved lives.
So today, @WHO unveiled a new team of scientists from around the world that will guide the search for the origins of #covid19 but also work on future outbreaks and more generally on emerging pathogens.
That might be criticised by some, @angie_rasmussen told me. But: "I think it is important for continuity and to assert that the first mission wasn’t a total wash"
"The number of weekly reported deaths from #covid19 continues to decline and is now at the lowest level in almost a year”, says @DrTedros at @WHO presser.
"But it’s still an unacceptably high level: almost 50,000 deaths a week, and the real number is certainly higher."
@DrTedros@WHO "Deaths are declining in every region except Europe, where several countries are facing fresh waves of cases and deaths”, says @drtedros.
@DrTedros@WHO “Of course, deaths are highest in the countries and populations with the least access to #covid19 vaccines”, says @DrTedros.
"We ask once again for the countries and companies that control the global supply of #covid19 vaccines to prioritize supply to COVAX and to AVAT now"
WHO’s expert group on immunization (SAGE) met last week to review evidence and is now recommending an additional #covid19 vaccine dose for two groups of people: 1. Anyone who is moderately or severely immunocompromised no matter which vaccine they received
2. Anyone 60 or over who received two doses of the inactivated vaccines from Sinopharm or Sinovac. (The evidence this is based on comes mostly from Latin American countries, where these have been used widely)
In both cases @WHO considers the additional dose to be part of the primary immunization series, so separate from the discussion about booster shots to shore up waning immunity.
“The development and approval of vaccines in record time took us to the summit of scientific achievement”, says @DrTedros in #covid19 presser.
“Now, we stand on the precipice of failure. If we don't make the benefits of science available to all people in all countries right now."
@DrTedros “High and upper middle income countries have used 75% of all vaccines produced so far, low income countries have received less than half of 1% of the world's vaccines”, says @DrTedros calling it a “horrifying inequity".
“In Africa, less than 5% of people are fully vaccinated."
@DrTedros "Today, WHO is launching the strategy to achieve global #COVID19 vaccination by mid-2022”, says @drtedros. Goal is 40% coverage in all countries by the end of this year, 70% by middle of next year.
"This is not a supply problem. It is an allocation problem"
A new preprint by @PeterDaszak, @nycbat and others attempts to show where the next coronavirus pandemic is most likely to begin and argues that there may be 400,000 hidden infections with SARSr-CoVs every year.
@PeterDaszak@nycbat First of all:
Yes, that is a really big number. And yes there is HUGE uncertainty in that.
The confidence interval goes all the way down to a single case and all the way up to more than 35 million!
We’ll get to that.
But let’s take a quick look at what the researchers did.
@PeterDaszak@nycbat They created a detailed map of the habitats of 23 bat species known to harbor SARSr-CoVs, then overlaid it with data on where humans live to create a map showing where the risk of spillover is highest: southern China, Vietnam, Cambodia, and on Java and other islands in Indonesia